Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03258190Phase 2Completed
Phase 2, randomised, double-blind trial in urolithiasis (2 arms), sponsored by Chulalongkorn University. Primary endpoint: Renal stone recurrence at 6 months. Started Jul 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03258190.